AMSA Pharm-free Scorecard 2010
A University of Arkansas for Medical Sciences
City: Little Rock State: AR
Commentary:

Summary: University of Arkansas for Medical Sciences has a model policy for the following domains: consulting, speaking, disclosure, samples, on-site education, off-site education and scholarship/trainee funds. This includes explicitly prohibiting participation in "speaker's bureaus." There is public disclosure of financial ties between physicians and industry through the institution's website and the provision of generic medication samples.  Also, sanctions are clearly listed in the policy.  Gifts domain can be improved by completely prohibiting all gifts. The updated policy includes improvements in the domains of Curriculum and Purchasing and Formularies.

Demographics: On average students spend 70% of their training at University of Arkansas Medical Center, 20% at Central Arkansas Veteran's Healthcare System John L. McClellan Memorial Veteran's Hospital , and 10% at Arkansas Children's Hospital. Submitted policies apply to faculty and staff of University of Arkansas Medical School in all work settings.  CAVHS and ACH each have administrative structures with “corresponding policies and procedures”.

Updates: The University of Arkansas for Medical Sciences submitted revised policies to the 2012-3 AMSA PharmFree Scorecard. Their grade remains an A. 

This institution's evaluation was last updated: 4/9/2013



Gifts & Meals 3 Gifts and meals are forbidden with a few minor exceptions, but these are mostly in the context of an employee otherwise being present for job-related duties.
Consulting relationships 3 The policy requires written and advanced approval from the Dean or Director, in addition to consulting relationships being described in a formal contract.
Industry-funded speaking relationships 3 The policy explicitly prohibits participation in "speaker's bureaus," governs speaking relationships by the consulting relationship policy and prevents industry from controlling the presentation content.
Disclosure 3 Public disclosure of financial ties between physicians and industry is implemented through the institution's website.
Pharmaceutical samples 3 The policy clearly prevents samples from being given directly to physicians by a pharmaceutical sales representative and the policy provides samples of generic medications.
Purchasing & Formularies 3 Committee members are required to disclose their financial conflicts of interest and if a conflict exists, "the committee member will not vote on the drug under consideration and may only provide expert advice after disclosure of the relationship."  Those with financial COIs may serve on the committee but must recuse themselves from all participation related to their SI.
Industry Sales Representatives 2 The policy requires industry sales representatives to meet with faculty by appointment only.
On-campus Education 3 The policy requires that all contributions be made to a central fund and be independent of industry control, including topics and materials.
Attendance at Industry-Sponsored Lectures & Meetings Off-Campus 3 The policy requires travel support approval from either the Department Chair, Director, Dean or Hospital CEO.
Industry Support for Scholarships & Funds for Trainees 3 The individual recipient of the funds is designated by the appropriate college or department, and not the industry.
Medical school curriculum 3 Extensive section on the facts about marketing, with references to several studies on the effects of marketing on physician behavior.
Do the policies specify an oversight mechanism? Yes The Conflict of Interest Office is the party responsible for general oversight.
Are there explicit sanctions for noncompliance? Yes The policy clearly references sanctions for noncompliance.
What the results mean...
3Model policy
2Good progress toward model policy
1No policy, or policy unlikely to have a substantial effect on behavior
0Did not report
N/APolicy not relevant to this institution (e.g., does not make purchasing decisions)